25 XP   0   0   10

IBEX Technologies Inc
Buy, Hold or Sell?

Let's analyse Ibex together

PenkeI guess you are interested in IBEX Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IBEX Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about IBEX Technologies Inc

I send you an email if I find something interesting about IBEX Technologies Inc.

Quick analysis of Ibex (30 sec.)










What can you expect buying and holding a share of Ibex? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.58
Expected worth in 1 year
C$0.74
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
C$0.16
Return On Investment
11.2%

For what price can you sell your share?

Current Price per Share
C$1.43
Expected price per share
C$1.42 - C$1.43
How sure are you?
50%

1. Valuation of Ibex (5 min.)




Live pricePrice per Share (EOD)

C$1.43

Intrinsic Value Per Share

C$0.35 - C$0.38

Total Value Per Share

C$0.93 - C$0.97

2. Growth of Ibex (5 min.)




Is Ibex growing?

Current yearPrevious yearGrowGrow %
How rich?$10.5m$7.1m$1.9m21.7%

How much money is Ibex making?

Current yearPrevious yearGrowGrow %
Making money$740.9k$310.7k$430.1k58.1%
Net Profit Margin52.8%22.1%--

How much money comes from the company's main activities?

3. Financial Health of Ibex (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#683 / 1031

Most Revenue
#464 / 1031

Most Profit
#141 / 1031

Most Efficient
#40 / 1031

What can you expect buying and holding a share of Ibex? (5 min.)

Welcome investor! Ibex's management wants to use your money to grow the business. In return you get a share of Ibex.

What can you expect buying and holding a share of Ibex?

First you should know what it really means to hold a share of Ibex. And how you can make/lose money.

Speculation

The Price per Share of Ibex is C$1.43. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ibex.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ibex, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.58. Based on the TTM, the Book Value Change Per Share is C$0.04 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ibex.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.021.7%0.032.1%0.010.9%0.010.7%0.010.7%
Usd Book Value Change Per Share0.021.6%0.032.1%0.011.0%0.010.7%0.021.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.021.6%0.032.1%0.011.0%0.010.7%0.021.1%
Usd Price Per Share0.74-0.73-0.36-0.32-0.27-
Price to Earnings Ratio7.60-18.06-21.90-12.90-38.17-
Price-to-Total Gains Ratio32.32-71.29-61.17-56.00--149.43-
Price to Book Ratio1.72-1.98-1.25-1.08-0.99-
Price-to-Total Gains Ratio32.32-71.29-61.17-56.00--149.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.052909
Number of shares949
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.01
Usd Total Gains Per Share0.030.01
Gains per Quarter (949 shares)28.039.60
Gains per Year (949 shares)112.1038.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011210203828
2022421407766
303363260115104
404484380154142
505615500192180
606736620230218
707857740269256
808978860307294
9010099980346332
100112111100384370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%22.06.00.078.6%22.06.00.078.6%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%16.04.00.080.0%21.07.00.075.0%21.07.00.075.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%16.04.00.080.0%21.07.00.075.0%21.07.00.075.0%

Fundamentals of Ibex

About IBEX Technologies Inc

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-03-19 15:44:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of IBEX Technologies Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ibex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • A Net Profit Margin of 39.4% means that $0.39 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IBEX Technologies Inc:

  • The MRQ is 39.4%. The company is making a huge profit. +2
  • The TTM is 52.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ39.4%TTM52.8%-13.5%
TTM52.8%YOY22.1%+30.7%
TTM52.8%5Y16.3%+36.5%
5Y16.3%10Y16.9%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ39.4%-159.2%+198.6%
TTM52.8%-202.3%+255.1%
YOY22.1%-263.0%+285.1%
5Y16.3%-452.4%+468.7%
10Y16.9%-589.0%+605.9%
1.1.2. Return on Assets

Shows how efficient Ibex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • 4.5% Return on Assets means that Ibex generated $0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IBEX Technologies Inc:

  • The MRQ is 4.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 6.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ4.5%TTM6.2%-1.7%
TTM6.2%YOY3.4%+2.8%
TTM6.2%5Y2.6%+3.6%
5Y2.6%10Y2.8%-0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5%-12.5%+17.0%
TTM6.2%-12.2%+18.4%
YOY3.4%-11.2%+14.6%
5Y2.6%-13.3%+15.9%
10Y2.8%-14.6%+17.4%
1.1.3. Return on Equity

Shows how efficient Ibex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • 5.7% Return on Equity means Ibex generated $0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IBEX Technologies Inc:

  • The MRQ is 5.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.7%TTM7.7%-2.0%
TTM7.7%YOY4.3%+3.4%
TTM7.7%5Y3.1%+4.5%
5Y3.1%10Y3.5%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7%-16.0%+21.7%
TTM7.7%-15.8%+23.5%
YOY4.3%-13.9%+18.2%
5Y3.1%-18.2%+21.3%
10Y3.5%-19.1%+22.6%

1.2. Operating Efficiency of IBEX Technologies Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ibex is operating .

  • Measures how much profit Ibex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IBEX Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.7%-1.7%
TTM1.7%YOY27.1%-25.4%
TTM1.7%5Y9.5%-7.8%
5Y9.5%10Y6.1%+3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM1.7%-208.5%+210.2%
YOY27.1%-280.2%+307.3%
5Y9.5%-459.9%+469.4%
10Y6.1%-596.9%+603.0%
1.2.2. Operating Ratio

Measures how efficient Ibex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of IBEX Technologies Inc:

  • The MRQ is 0.939. The company is less efficient in keeping operating costs low.
  • The TTM is 1.055. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.939TTM1.055-0.116
TTM1.055YOY1.036+0.019
TTM1.0555Y1.263-0.208
5Y1.26310Y1.356-0.093
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9392.817-1.878
TTM1.0553.181-2.126
YOY1.0363.609-2.573
5Y1.2635.554-4.291
10Y1.3567.396-6.040

1.3. Liquidity of IBEX Technologies Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ibex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.08 means the company has $5.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of IBEX Technologies Inc:

  • The MRQ is 5.076. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.144. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.076TTM6.144-1.068
TTM6.144YOY5.553+0.591
TTM6.1445Y5.412+0.732
5Y5.41210Y5.731-0.318
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0763.987+1.089
TTM6.1444.440+1.704
YOY5.5535.569-0.016
5Y5.4126.158-0.746
10Y5.7316.492-0.761
1.3.2. Quick Ratio

Measures if Ibex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • A Quick Ratio of 0.70 means the company can pay off $0.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IBEX Technologies Inc:

  • The MRQ is 0.697. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.783. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.697TTM0.783-0.086
TTM0.783YOY0.515+0.268
TTM0.7835Y0.716+0.067
5Y0.71610Y0.839-0.122
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6973.653-2.956
TTM0.7834.158-3.375
YOY0.5155.515-5.000
5Y0.7166.012-5.296
10Y0.8396.206-5.367

1.4. Solvency of IBEX Technologies Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ibex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ibex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.20 means that Ibex assets are financed with 19.9% credit (debt) and the remaining percentage (100% - 19.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IBEX Technologies Inc:

  • The MRQ is 0.199. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.196. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.199TTM0.196+0.003
TTM0.196YOY0.207-0.012
TTM0.1965Y0.195+0.001
5Y0.19510Y0.194+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1990.336-0.137
TTM0.1960.330-0.134
YOY0.2070.267-0.060
5Y0.1950.367-0.172
10Y0.1940.378-0.184
1.4.2. Debt to Equity Ratio

Measures if Ibex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ibex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 24.8% means that company has $0.25 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IBEX Technologies Inc:

  • The MRQ is 0.248. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.244. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.248TTM0.244+0.004
TTM0.244YOY0.265-0.021
TTM0.2445Y0.2440.000
5Y0.24410Y0.243+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2480.376-0.128
TTM0.2440.398-0.154
YOY0.2650.334-0.069
5Y0.2440.431-0.187
10Y0.2430.476-0.233

2. Market Valuation of IBEX Technologies Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ibex generates.

  • Above 15 is considered overpriced but always compare Ibex to the Biotechnology industry mean.
  • A PE ratio of 7.60 means the investor is paying $7.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IBEX Technologies Inc:

  • The EOD is 10.873. Based on the earnings, the company is underpriced. +1
  • The MRQ is 7.604. Based on the earnings, the company is underpriced. +1
  • The TTM is 18.057. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD10.873MRQ7.604+3.270
MRQ7.604TTM18.057-10.454
TTM18.057YOY21.895-3.838
TTM18.0575Y12.904+5.153
5Y12.90410Y38.172-25.268
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.873-2.697+13.570
MRQ7.604-2.422+10.026
TTM18.057-2.709+20.766
YOY21.895-4.116+26.011
5Y12.904-6.257+19.161
10Y38.172-6.478+44.650
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IBEX Technologies Inc:

  • The EOD is 22.669. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 15.852. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.738. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD22.669MRQ15.852+6.817
MRQ15.852TTM16.738-0.886
TTM16.738YOY4.037+12.702
TTM16.7385Y4.467+12.271
5Y4.46710Y3.191+1.276
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.669-3.344+26.013
MRQ15.852-2.939+18.791
TTM16.738-3.486+20.224
YOY4.037-5.592+9.629
5Y4.467-8.464+12.931
10Y3.191-8.872+12.063
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ibex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.72 means the investor is paying $1.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of IBEX Technologies Inc:

  • The EOD is 2.463. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.723. Based on the equity, the company is underpriced. +1
  • The TTM is 1.980. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.463MRQ1.723+0.741
MRQ1.723TTM1.980-0.257
TTM1.980YOY1.249+0.731
TTM1.9805Y1.081+0.899
5Y1.08110Y0.989+0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4632.198+0.265
MRQ1.7232.042-0.319
TTM1.9802.121-0.141
YOY1.2492.907-1.658
5Y1.0813.682-2.601
10Y0.9894.114-3.125
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of IBEX Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0310.040-23%0.019+65%0.014+125%0.021+49%
Book Value Per Share--0.5810.504+15%0.393+48%0.357+63%0.338+72%
Current Ratio--5.0766.144-17%5.553-9%5.412-6%5.731-11%
Debt To Asset Ratio--0.1990.196+1%0.207-4%0.195+2%0.194+2%
Debt To Equity Ratio--0.2480.244+2%0.265-6%0.244+2%0.243+2%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0330.041-19%0.017+93%0.014+131%0.014+139%
Free Cash Flow Per Share--0.0160.010+52%0.032-51%0.018-14%0.018-14%
Free Cash Flow To Equity Per Share--0.0080.006+36%0.030-73%0.013-38%0.013-38%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.385--------
Intrinsic Value_10Y_min--0.346--------
Intrinsic Value_1Y_max--0.069--------
Intrinsic Value_1Y_min--0.068--------
Intrinsic Value_3Y_max--0.184--------
Intrinsic Value_3Y_min--0.176--------
Intrinsic Value_5Y_max--0.271--------
Intrinsic Value_5Y_min--0.254--------
Market Cap35054448.000+30%24644244.00024555746.170+0%12215892.670+102%10606093.116+132%9131278.261+170%
Net Profit Margin--0.3940.528-25%0.221+78%0.163+141%0.169+133%
Operating Margin---0.017-100%0.271-100%0.095-100%0.061-100%
Operating Ratio--0.9391.055-11%1.036-9%1.263-26%1.356-31%
Pb Ratio2.463+30%1.7231.980-13%1.249+38%1.081+59%0.989+74%
Pe Ratio10.873+30%7.60418.057-58%21.895-65%12.904-41%38.172-80%
Price Per Share1.430+30%1.0000.993+1%0.493+103%0.428+134%0.369+171%
Price To Free Cash Flow Ratio22.669+30%15.85216.738-5%4.037+293%4.467+255%3.191+397%
Price To Total Gains Ratio46.212+30%32.31671.286-55%61.175-47%56.004-42%-149.429+562%
Quick Ratio--0.6970.783-11%0.515+35%0.716-3%0.839-17%
Return On Assets--0.0450.062-27%0.034+32%0.026+77%0.028+62%
Return On Equity--0.0570.077-26%0.043+32%0.031+80%0.035+64%
Total Gains Per Share--0.0310.040-23%0.019+65%0.014+125%0.021+49%
Usd Book Value--10534103.4679173493.960+15%7179439.490+47%6517129.135+62%6160139.534+71%
Usd Book Value Change Per Share--0.0230.030-23%0.014+65%0.010+125%0.015+49%
Usd Book Value Per Share--0.4270.371+15%0.289+48%0.263+63%0.249+72%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0240.030-19%0.013+93%0.010+131%0.010+139%
Usd Free Cash Flow--286165.204188528.511+52%590622.677-52%268394.493+7%191710.352+49%
Usd Free Cash Flow Per Share--0.0120.008+52%0.024-51%0.014-14%0.014-14%
Usd Free Cash Flow To Equity Per Share--0.0060.004+36%0.022-73%0.010-38%0.010-38%
Usd Market Cap25810590.062+30%18145556.85718080395.905+0%8994561.773+102%7809266.361+132%6723360.184+170%
Usd Price Per Share1.053+30%0.7360.731+1%0.363+103%0.315+134%0.272+171%
Usd Profit--596608.428740972.928-19%310781.554+92%257644.992+132%249221.535+139%
Usd Revenue--1515457.0781435485.694+6%1447355.402+5%1149632.129+32%1081111.762+40%
Usd Total Gains Per Share--0.0230.030-23%0.014+65%0.010+125%0.015+49%
 EOD+4 -4MRQTTM+16 -17YOY+22 -115Y+20 -1310Y+21 -12

3.2. Fundamental Score

Let's check the fundamental score of IBEX Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.873
Price to Book Ratio (EOD)Between0-12.463
Net Profit Margin (MRQ)Greater than00.394
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.697
Current Ratio (MRQ)Greater than15.076
Debt to Asset Ratio (MRQ)Less than10.199
Debt to Equity Ratio (MRQ)Less than10.248
Return on Equity (MRQ)Greater than0.150.057
Return on Assets (MRQ)Greater than0.050.045
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of IBEX Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.430
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-10-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets17,851
Total Liabilities3,544
Total Stockholder Equity14,307
 As reported
Total Liabilities 3,544
Total Stockholder Equity+ 14,307
Total Assets = 17,851

Assets

Total Assets17,851
Total Current Assets11,036
Long-term Assets6,815
Total Current Assets
Cash And Cash Equivalents 8,746
Net Receivables 1,515
Inventory 234
Total Current Assets  (as reported)11,036
Total Current Assets  (calculated)10,495
+/- 541
Long-term Assets
Property Plant Equipment 3,693
Long-term Assets  (as reported)6,815
Long-term Assets  (calculated)3,693
+/- 3,122

Liabilities & Shareholders' Equity

Total Current Liabilities2,174
Long-term Liabilities1,370
Total Stockholder Equity14,307
Total Current Liabilities
Accounts payable 1,905
Total Current Liabilities  (as reported)2,174
Total Current Liabilities  (calculated)1,905
+/- 269
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,639
Long-term Liabilities  (as reported)1,370
Long-term Liabilities  (calculated)1,639
+/- 269
Total Stockholder Equity
Total Stockholder Equity (as reported)14,307
Total Stockholder Equity (calculated)0
+/- 14,307
Other
Capital Stock52,300
Common Stock Shares Outstanding 24,644
Net Invested Capital 14,307
Net Working Capital 8,862
Property Plant and Equipment Gross 7,665



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-31
> Total Assets 
6,999
7,293
9,535
9,809
8,979
9,346
9,447
9,250
9,198
8,889
8,387
8,881
8,815
9,453
8,593
9,020
8,885
9,115
9,458
10,097
10,724
12,113
12,974
13,600
13,196
14,090
16,831
17,851
17,85116,83114,09013,19613,60012,97412,11310,72410,0979,4589,1158,8859,0208,5939,4538,8158,8818,3878,8899,1989,2509,4479,3468,9799,8099,5357,2936,999
   > Total Current Assets 
4,470
4,371
4,137
4,391
3,704
4,085
4,293
4,124
4,142
3,835
3,714
3,604
3,633
5,365
4,915
5,202
5,094
5,307
5,829
6,467
7,150
7,958
9,026
9,626
8,834
9,763
10,228
11,036
11,03610,2289,7638,8349,6269,0267,9587,1506,4675,8295,3075,0945,2024,9155,3653,6333,6043,7143,8354,1424,1244,2934,0853,7044,3914,1374,3714,470
       Cash And Cash Equivalents 
3,114
3,001
3,005
3,109
2,709
2,696
3,140
2,858
3,327
2,981
2,580
2,500
3,004
2,843
3,706
4,161
3,851
4,211
4,434
5,209
6,210
6,960
7,641
8,159
7,490
7,518
8,547
8,746
8,7468,5477,5187,4908,1597,6416,9606,2105,2094,4344,2113,8514,1613,7062,8433,0042,5002,5802,9813,3272,8583,1402,6962,7093,1093,0053,0013,114
       Net Receivables 
771
741
544
745
542
963
718
833
548
462
833
745
328
1,044
751
644
799
678
955
863
553
591
991
1,089
1,042
1,569
902
1,515
1,5159021,5691,0421,0899915915538639556787996447511,044328745833462548833718963542745544741771
       Inventory 
511
463
478
418
373
289
345
303
176
250
146
220
239
238
233
265
245
301
319
300
334
261
227
243
214
244
171
234
234171244214243227261334300319301245265233238239220146250176303345289373418478463511
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
5,054
4,673
5,278
5,182
4,088
3,678
3,866
3,791
3,809
3,629
3,630
3,574
4,156
3,922
3,974
4,362
4,327
6,604
6,815
6,8156,6044,3274,3623,9743,9224,1563,5743,6303,6293,8093,7913,8663,6784,0885,1825,2784,6735,054000000000
       Property Plant Equipment 
2,530
2,921
2,920
2,975
2,831
2,818
2,742
2,744
2,675
2,672
2,211
2,835
2,739
1,645
1,542
1,740
1,665
1,683
1,709
1,712
1,655
2,237
2,672
2,724
3,112
3,077
3,443
3,693
3,6933,4433,0773,1122,7242,6722,2371,6551,7121,7091,6831,6651,7401,5421,6452,7392,8352,2112,6722,6752,7442,7422,8182,8312,9752,9202,9212,530
       Intangible Assets 
0
0
34
0
0
0
29
0
0
0
20
0
0
0
10
0
0
0
2
0
0
0
0
0
0
0
38
0
038000000020001000020000290003400
       Other Assets 
0
0
2,443
2,443
2,443
2,443
2,382
2,382
2,382
2,382
2,442
2,442
2,442
2,442
2,126
2,126
2,126
2,126
1,918
1,918
1,918
1,918
1,250
1,250
1,250
0
0
0
0001,2501,2501,2501,9181,9181,9181,9182,1262,1262,1262,1262,4422,4422,4422,4422,3822,3822,3822,3822,4432,4432,4432,44300
> Total Liabilities 
1,601
1,830
1,781
1,903
1,441
1,555
1,657
1,655
1,550
1,738
1,813
2,233
2,161
2,168
1,474
1,788
1,352
1,244
1,556
1,529
1,589
2,405
3,227
3,188
2,681
2,683
3,224
3,544
3,5443,2242,6832,6813,1883,2272,4051,5891,5291,5561,2441,3521,7881,4742,1682,1612,2331,8131,7381,5501,6551,6571,5551,4411,9031,7811,8301,601
   > Total Current Liabilities 
517
707
788
889
488
572
674
676
585
767
876
824
801
1,762
1,110
1,218
818
746
1,097
1,109
1,207
1,387
1,751
1,784
1,322
1,369
1,798
2,174
2,1741,7981,3691,3221,7841,7511,3871,2071,1091,0977468181,2181,1101,762801824876767585676674572488889788707517
       Short-term Debt 
1,110
1,152
48
50
49
51
53
54
54
56
56
56
57
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000057565656545453514950481,1521,110
       Short Long Term Debt 
1,110
1,152
48
50
49
51
53
54
54
56
56
56
57
1,006
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,00657565656545453514950481,1521,110
       Accounts payable 
468
655
739
839
439
521
621
622
530
711
820
614
588
592
944
1,032
639
578
941
905
1,015
1,225
1,575
1,556
1,106
1,165
1,585
1,905
1,9051,5851,1651,1061,5561,5751,2251,0159059415786391,032944592588614820711530622621521439839739655468
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
614
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000061400000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
965
971
937
1,409
1,360
407
364
570
534
498
459
420
381
1,018
1,476
1,404
1,359
1,314
1,426
1,370
1,3701,4261,3141,3591,4041,4761,0183814204594985345703644071,3601,40993797196500000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
639
602
570
530
756
713
666
616
624
573
1,180
1,625
1,632
1,576
1,518
1,639
1,639
1,6391,6391,5181,5761,6321,6251,18057362461666671375653057060263900000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
0
0
0
0
0
00000270000000000000000000000
> Total Stockholder Equity
5,398
5,462
7,754
7,906
7,537
7,791
7,790
7,595
7,648
7,151
6,574
6,648
6,654
7,284
7,120
7,232
7,533
7,871
7,902
8,567
9,135
9,709
9,747
10,412
10,515
11,407
13,607
14,307
14,30713,60711,40710,51510,4129,7479,7099,1358,5677,9027,8717,5337,2327,1207,2846,6546,6486,5747,1517,6487,5957,7907,7917,5377,9067,7545,4625,398
   Common Stock
52,660
52,660
52,660
52,660
52,660
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,672
52,680
52,680
52,680
52,680
52,680
52,680
52,597
52,597
0
0
0
00052,59752,59752,68052,68052,68052,68052,68052,68052,67252,67252,67252,67252,67252,67252,67252,67252,67252,67252,67252,67252,66052,66052,66052,66052,660
   Retained Earnings -39,207-40,017-42,241-43,132-43,232-43,911-43,946-44,515-44,921-45,585-45,615-45,948-46,197-46,347-46,651-47,277-47,248-47,313-46,729-46,211-46,254-46,045-46,026-46,235-45,820-45,950-48,308-48,310
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
480
527
458
480
449
477
487
494
495
506
501
501
499
486
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000486499501501506495494487477449480458527480



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-07-31)

Gross Profit (+$)
totalRevenue7,492
Cost of Revenue-2,292
Gross Profit5,2005,200
 
Operating Income (+$)
Gross Profit5,200
Operating Expense-5,644
Operating Income1,848-444
 
Operating Expense (+$)
Research Development671
Selling General Administrative3,049
Selling And Marketing Expenses-
Operating Expense5,6443,719
 
Net Interest Income (+$)
Interest Income360
Interest Expense-98
Other Finance Cost-0
Net Interest Income262
 
Pretax Income (+$)
Operating Income1,848
Net Interest Income262
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,0181,940
EBIT - interestExpense = -98
3,894
3,991
Interest Expense98
Earnings Before Interest and Taxes (EBIT)-2,116
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,018
Tax Provision--1,876
Net Income From Continuing Ops3,8943,894
Net Income3,894
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-92-262
 

Technical Analysis of Ibex
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ibex. The general trend of Ibex is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ibex's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IBEX Technologies Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.43 < 1.43 < 1.43.

The bearish price targets are: 1.42 > 1.42 > 1.42.

Tweet this
IBEX Technologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IBEX Technologies Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IBEX Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartIBEX Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IBEX Technologies Inc. The current adx is .

IBEX Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IBEX Technologies Inc.

IBEX Technologies Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Relative Strength Index (RSI) ChartIBEX Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IBEX Technologies Inc.

IBEX Technologies Inc Daily Stochastic Oscillator ChartIBEX Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Commodity Channel Index (CCI) ChartIBEX Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartIBEX Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IBEX Technologies Inc.

IBEX Technologies Inc Daily Williams %R ChartIBEX Technologies Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IBEX Technologies Inc.

IBEX Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Average True Range (ATR) ChartIBEX Technologies Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IBEX Technologies Inc.

IBEX Technologies Inc Daily On-Balance Volume (OBV) ChartIBEX Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IBEX Technologies Inc.

IBEX Technologies Inc Daily Money Flow Index (MFI) ChartIBEX Technologies Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IBEX Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

IBEX Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IBEX Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.430
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ibex with someone you think should read this too:
  • Are you bullish or bearish on Ibex? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ibex? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IBEX Technologies Inc

I send you an email if I find something interesting about IBEX Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about IBEX Technologies Inc.

Receive notifications about IBEX Technologies Inc in your mailbox!